EDIT vs LHX · rev $14.7M vs P/E 34, rev $5.88B
Editas Medicine Inc (EDIT) versus L3Harris Technologies Inc (LHX) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
L3Harris Technologies Inc (LHX) is a aerospace & defense company listed on US.
Latest reported EDIT revenue for 2026-06-30 was $14.7M. Net income was -$43.2M. EDIT currently screens at market cap $375.2M.
Latest reported LHX revenue for 2026-07-03 was $5.88B. Net income was $600.0M. Revenue was up 2.4% from 2026-04-03 to 2026-07-03. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
EDIT currently screens at market cap $375.2M. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
Not investment advice. Open the EDIT and LHX stock pages for the full models.
Not investment advice.